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Localisation of mRNA encoding the four AMPA glutamate receptor subunits in the rat adrenal gland was investigated using in situ hybridisation. 
GluRl is found in the zona glomerulosa of the cortex, GluR3 in the remaining parts of the cortex, GluR2 in adrenal medullary cells and GluR4 
at a very low level in the zona glomerulosa. All four receptor mRNAs are found in medullary ganglion cells. The flip form of GluR2 and GluR3 
dominate and the GluR2 mRNA is present in the arginine encoding form. Different cell populations of the adrenal gland may express homomeric 
forms of different receptor subtypes. 
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1. INTRODUCTION 
Glutamate is the major excitatory neurotransmitter 
of the central nervous system and glutamate receptors 
may be divided into ion-channel forming (ionotropic) 
and G-protein coupled (metabotropic) receptors. The 
ionotropic glutamate receptors are a family of ligand- 
gated ion channels that may be further subdivided into 
NMDA and non-NMDA receptors [1,2]. In the latter 
group the best characterised members are the family of 
AMPA receptors, and currently four st~cturally re- 
lated molecular subunits are known in this family [3-q. 
The combination of subunits in the receptor complex 
determines the functional properties of the channel; 
when the GluR2 subunit is included, the formed chan- 
nels will have a low permeability to calcium ions [7-lo]. 
The four AMPA subunits have been labelled GluR14, 
GluRA-D or al-rz4. In this presentation the numbering 
GluRl-GluR4 will be used. Until now, the AMPA re- 
ceptors have only been demonstrated in the central 
nervous system [3-6] and in the retina [ 11,121. 
sense- and anti-sense RNA probes and in situ hybridisation were done 
as described 1131, except that the proteinase K step was omitted, the 
final concentration of radioactivity in the hybridisation solution was 
50.000 cpm/ml, hybridisation was done at 57’C and washing of sec- 
tions in 50% formamide solution at 62’C and 67’C. Following expo- 
sure to beta-max film (Amersham, UK), sections were coated with 
emulsion and exposed for 29 days. 
The following cDNA fragments coding for the N- terminal parts of 
the four rat AMPA glutamate receptors were isolated by PCR [14] 
based on the published sequence IS], inserted into pBIuescript vector, 
analysed by DNA sequencing and used for probe preparation: 
GluRl(bp. no. l-850), GluRZ(bp. no. l-934), GluR3@p. no. l-756) 
and GluR4(bp. no. l-1058). 
RNA was prepared from freshly removed or frozen rat tissue using 
the t~~yanate-phenol extraction method [IS] as modified for use 
with the RNaid kit (BiolOl): 2.5 ml of cell lysis solution was used lyse 
4 adrenal glands and these were homogenized on ice in a Dounce glass 
homogenizer. Consecutive xtractions were performed with 2.5 ml of 
acid phenol and 2 x 1 ml of chloroform/isoamylalcohol (25:l). The 
remaining part of the procedure was as recommended by the man- 
ufacturer. Finally the RNA was dissolved in water and the absorption 
at 260 and 280 nm. measured. Only RNA with an OD ratio 260 
nm/280 nm of > 1.95 was used. 
2. MATERIALS AND ME~ODS 
Male Sprague-Dawley rats (weighing appox. 200 g) were used. 
Adrenal glands were removed after perfusion fixation of the animal 
with freshly prepared 4% paraformaldehyde and processed as previ- 
ously described [13], except that isopentane cooled on dry-ice, was 
used for freezing instead of Freon 22. Preparation of 35S-labelled 
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Abbreviations: AMPA, a-amino-3-hydroxy-5-methyl-isoxazole-4-pro- 
pionate; GluR, glutamate receptor; NMDA, Wmethyl-o-aspartate; 
PCR, polymerase chain reaction. 
cDNA was synthesised from 4 mg of total RNA using Moloney 
murine leukemia virus reverse transcriptase primed with 0.2 mg of 
random hexamers in a reaction mixture of 45 mM Tris (PH 8.3), 68 
mM KQ, 15 mM dithio~~itol, 9 mM M&l,, 0.08 mlJm1 bovine 
semm albumin and 1.8 mM of each d~xynucl~tide for 60 min at 
37°C. The entire cDNA synthesis reaction was used for PCR after 
diluting 3-fold with water and addition of 60 pmol of each primer. Taq 
polymerase (2 units) was added after denaturation and equlibration 
at the annealing temperature. For analysis of the flip/flop region 
amplification was for 35 cycles at 95W55”CY 37°C (each for 1 min) 
using pairs of the following 21- mer oligonucleotides: GluRl: 5’ posi- 
tion 2074 (Y- GAACCATCCGTGTTTGTTCTT) and 3’ position 
2541 (5’-ATGGCTTCATTGATGGATTGC); GluR2 80: 5’ position 
2070 (S-AATGTGGACTTATATGAGGAG) and 3’ position 2558 
(5’-AGGAAGATGGGTTAATATTCT); GluR3: 5’ position 2109 (5’- 
AGAGCCATCTGTGTITACCAA) and 3’ position 2556 (S-TTTT- 
GGGTG’lTCTl’TGTGAGT); GluR4: 5’ position 2074 (5’-ATGTG- 
GACCTACATGCGATCG) and 3’ position 2557 (5’- GGCTTTGT- 
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TTCTTGTGGCTTC). For analysis of GluR2 posttranscriptional ed- 
iting PCR amplification was done for 35 cycles at 95W56W37”C 
(each for 1 min) using the oligonucleotides: S-GGAATGGTATG- 
GTTGGAGAGC and S-AGTTAGCCGTGTAGGAGGAGA. 
DNA sequencing of the PCR fragment purified by Geneclean (Bio 
101) was done using Sequenase (USB) according to manufacturers 
recommendations. 
3. RESULTS AND DISCUSSION 
In situ hybridisation to sections of rat adrenal me- 
dulla showed a differential pattern of expression for the 
four AMPA glutamate receptors (Fig. l), with a strong 
signal using the anti-sense RNA probes, and lack of 
signal using RNA transcribed from the complementary 
strand, except for the unspecific binding observed to a 
blood vessel in the per&adrenal fat (Fig. 1). The strong- 
est expression was seen for the GluR3 (Fig. le). Exam- 
ination at the histological level (Fig. 2) confirmed a 
strong signal in most cortical cells, except those of the 
zona glomerulosa (Fig. 2a and c). The cells of the cortex 
zona glomerulosa showed signal for the GluRl (Figs. 
la and 2b), while all medullary cells showed signal for 
GluR2 mRNA (Figs. lc and 2d). In the medulla, the 
sympathetic ganglion cells, discernible by their size 
showed positive signal for all four receptors (Fig. 3). A 
weak signal could be seen for the GluR4 mRNA in the 
outer layer of the cortex (Fig. lg). To further character- 
ise the mRNA present in the adrenal gland, mRNA was 
purified, cDNA synthesised after random priming and 
PCR amplification performed. The oligonucleotides 
used for the PCR were selected to amplify the region 
that is alternatively spliced in the receptors to yield the 
two different flip/flop forms of the receptor mRNA [16] 
and to avoid cross-amplification between receptor sub- 
types. The oligonucleotides were further selected so that 
a restriction endonuclease site specific for the flip or flop 
region would not be present in the remaining fragment. 
Cutting of the fragment with this restriction endonu- 
clease could then give information on whether the flip 
or the flop version of the mRNA was found. Under the 
annealing conditions used (57’(Z), amplification from 
rat adrenal mRNA only showed the approx. 500 bp 
fragment when using the oligonucleotide pairs for 
GluR2 and GluR3, presumably because of to low 
amount of the GluRl and GluR4 mRNA being present 
in the total adrenal gland mRNA. Together with similar 
fragments amplified from cerebral cortex and cerebel- 
lum RNA these fragments were cut with restriction en- 
donucleases, precipitated with ethanol and analysed by 
agarose gel electrophoresis (Fig. 4). The cerebral cortex 
mRNA and cerebellar mRNA contain both flip and 
flop forms as previously reported [ 171, while the adrenal 
gland mRNA contains mainly the flip form of the 
mRNA. In addition to the flip/flop variation the GluR2 
mRNA is posttranscriptionally modified to insert a 
codon for arginine in the second transmembrane do- 
main, determining the calcium permeability of the 
Fig. 1. Film images of rat adrenal gland sections hybrid&d using 
anti-sense (a, c, e, g) and sense RNA probes (b, d, f, h) to the four 
different AMPA glutamate receptors: GluRl (a, b), GluR2 (c, d), 
GluR3 (e, f) and GluR4 (g, h). Micrographs prepared from beta-max 
film exposed for 5 days. Magnification 5.9 x. 
formed channel [8]. To determine which form is found 
in the adrenal medulla a 459 bp fragment was amplified 
from cDNA synthesised from adrenal gland mRNA 
(result not shown). The DNA sequence of this region of 
the PCR fragment was determined. and found to be 
identical to the edited version reported [8]. At least 80% 
of the adrenal gland GluR2 mRNA thus encodes a 
presumed low-calcium-permeable r ceptor. 
The binding of [3H&lutamate to the adrenal gland 
has previously been reported in a number of different 
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species, including the rat. The reports are contradictory and further indicate that in contrast to most regions of 
with respect o the pharmacological profile of displace- 
ment of the [3HJglutamate binding and to whether stim- 
the brain:, homomeric AMPA glutamate receptors, 
composed only of one subtype, are likely to be formed 
u&ion with glutamate may affect release of catechol- 
amines [1843. 
Our findings strongly support the presence of ion- 
otropic ~utamate receptors in the rat adrenal gland, 
in this tissue. Future experiments using subtype selec- 
tive antibodies and possibly electrophysiological meas- 
urements on adrenal gland cells will reveal if this is the 
case. 
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Fig. 3. Micrographs using anti-sense (a, c, e, and g) and sense RNA probes (b, d, f, h) to the four difkrent AMPA gh~tamate r ceptors in rat adrenal 
medulla: GluRl (a, b), GluR2 (c, d), GIuR3 (e, r) and GluR4 (g, h). Note the signal over medulky ganglion cells for alI four receptor subtypes 
(straight arrows in a, c, e and g) and the presence of a few small meduilary cells showing signal for GluR3 in the medulla (curved arrows in e). 
Magnifkation 284 x. 
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GIuR2 GIuR3 
Ctx crb Adr Ctx Crb Adr 
-AS -AS-AS-NS -NS -NS 
_..___ “... ._______ 
Fig. 4. Restriction enzyme analysis of “P-labelled PCR ampliication products prepared from cerebral cortex, cerebellar or adrenal RNA using 
oligonucleotides flanking the flip/flop area of GluR2 and GluR3. Enzyme symbol explanation: -, no enzyme; A, AvuI; S, StuI; N, NC& The presence 
of an AvaI (in GluR2) or Nctl (in GluR3) site demonstrates the flip form, while &I (in both GluR2 and GluR3) demonstrates the flop form. Sizes 
of expected bands are indicated in basepairs. 
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